4.3 Article

Longitudinal Experience With and Impressions of COVID-19-Related Clinical Research Changes

Journal

JCO ONCOLOGY PRACTICE
Volume 18, Issue 1, Pages 74-E107

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1200/OP.21.00169

Keywords

-

Categories

Funding

  1. National Cancer Institute Midcareer Investigator Award in Patient-Oriented Research [K24CA201543-01]
  2. Biostatistics Shared Resource of the Harold C. Simmons Comprehensive Cancer Center [5P30 CA142543]
  3. UT Southwestern Academic Information Systems (CTSA NIH) [UL1TR001105]

Ask authors/readers for more resources

The COVID-19 pandemic has brought about significant changes in clinical research, such as remote consent, telehealth, and remote study monitoring. A survey conducted among cancer research professionals showed that perceptions of these adjustments remained favorable over time, and individuals with experience were more likely to recommend the continuation of these changes in the future.
PURPOSE: The COVID-19 pandemic has led to profound changes in clinical research, including remote consent, telehealth, off-site procedures, shipment of therapy, and remote study monitoring. We assessed longitudinal perceptions of these adjustments among clinical research professionals. METHODS: We distributed an anonymous survey assessing experiences, perceptions, and recommendations regarding COVID-19-related clinical research adjustments to cancer clinical research office personnel in May 2020 and again in November 2020. Responses were compared using Fisher's exact and Mann-Whitney U tests. RESULTS: A total of 90 of 102 invited research personnel (88%) responded. Fifty-three (59%) reported participating in both initial and follow-up surveys. The proportion of respondents reporting personal experience with COVID-19-related adjustments increased over time, particularly for remote initial consent (29% v 4%), remote reconsent (24% v 9%), and remote study monitoring (36% v 22%). Perceived impact of COVID-19-related adjustments on data quality (P = .02) and patient experience (P = .002) improved significantly. However, perceived effect on patient safety (P = .02) and respondent's experience (P = .09) became less favorable. Individuals with personal experience with the adjustment were more likely to recommend continuing remote consent (62% v 38%; P = .04), remote monitoring (69% v 45%; P = .05), and therapy shipment (67% v 35%; P = .01) after the COVID-19 pandemic, with nonsignificant trends for off-site diagnostics (44% v 24%; P = .13) and telehealth visits (66% v 45%; P = .08). CONCLUSION: More than 6 months into the global pandemic, perceptions of COVID-19-related clinical research changes remain favorable. Experienced individuals are more likely to recommend that these changes continue in the future.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available